Orbit Genomics Has Been Selected For The Inaugural Cohort of Startups In CancerX’s Accelerator Program

We are thrilled to announce that Orbit Genomics has been selected for the inaugural cohort of startups in CancerX’s Accelerator program!

CancerX is a public-private partnership announced by The White House as a national accelerator to boost innovation in the fight against cancer as part of the reignited Cancer Moonshot.

A team of Accelerator Champions and judges from the CancerX community led three rounds of judging earlier this year to select the cohort group. We are honored to be included with these impressive startups: The Blue Box, C the Signs, Cancer Insights, Curvia, EnteroTrack, Gesund.ai, Gray Oncology, LindAI, Mika Health, Navya, Oatmeal Health, Realyze Intelligence, Reimagine Care, SurvivorPlan, and Xanthos.

We look forward to working with the CancerX mentors to accelerate bringing OrbiSeq-L to market.

About CancerX Accelerator: CancerX Accelerator uniquely brings together a community of champions, innovators, and users of digital health in oncology to generate and scale ideas that have the potential to solve unmet needs in clinical delivery for cancer patients and providers.

Sign up to receive information about CancerX news.